関連する実験動画
Updated: May 5, 2026
11:09
Revealing the Cytoskeletal Organization of Invasive Cancer Cells in 3D
Published on: October 26, 2013
16.1K
ヒト心筋コラーゲン線維の3次元イメージング：トリパンブルー染色
I G Pochinka1, A A Frolov2, K V Kuzmichev3
1MD, DSc, Associate Professor, Head of the Department of Endocrinology and Internal Medicine; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
Sovremennye tekhnologii v meditsine
|December 22, 2025
まとめ
本研究では、STEMI患者に対する経皮的冠動脈インターベンション後のリフロー不良現象に関連する特定の一塩基多型（SNP）を特定した。これらのSNPを用いた遺伝的スケールは、この合併症を予測するのに役立つ可能性がある。
科学分野:
- Cardiology; Genetics; Interventional Cardiology
背景:
- The no-reflow phenomenon is a complication of percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI).; Identifying genetic factors associated with no-reflow can improve patient risk stratification and management.
研究 の 目的:
- To investigate the association between selected single nucleotide polymorphisms (SNPs) and the development of no-reflow during PCI in STEMI patients.; To develop a genetic scale for predicting no-reflow post-PCI.
主な方法:
- A matched case-control study involving 80 STEMI patients (40 with no-reflow, 40 without).; Assessment of multiple SNPs, including those in ADD1, CYP11B2, and MTHFR genes.; No-reflow defined by TIMI flow grade <3 or Myocardial blush grade <2 post-PCI.
主要な成果:
- SNPs rs4961 (ADD1), rs1799998 (CYP11B2), and rs1801133 (MTHFR) were significantly associated with no-reflow (p<0.05).; A genetic prognostic scale combining these SNPs showed a positive predictive value of 0.91 and an AUC of 0.724.; Each point increase on the scale correlated with a 5.39-fold increased odds of no-reflow development (p=0.04).
結論:
- Specific SNPs in ADD1, CYP11B2, and MTHFR genes are linked to the no-reflow phenomenon in STEMI patients undergoing PCI.; The developed genetic scale demonstrates potential for predicting no-reflow, aiding clinical decision-making.
